<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ultrasound Obstet Gynecol</journal-id><journal-id journal-id-type="iso-abbrev">Ultrasound Obstet Gynecol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1469-0705</journal-id><journal-id journal-id-type="publisher-id">UOG</journal-id><journal-title-group><journal-title>Ultrasound in Obstetrics &#x00026; Gynecology</journal-title></journal-title-group><issn pub-type="ppub">0960-7692</issn><issn pub-type="epub">1469-0705</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Ltd.</publisher-name><publisher-loc>Chichester, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1002/uog.22049</article-id><article-id pub-id-type="publisher-id">UOG22049</article-id><article-categories><subj-group subj-group-type="overline"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Why we should not stop giving aspirin to pregnant women during the <styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19 pandemic</article-title><alt-title alt-title-type="right-running-head">Aspirin, pregnancy and COVID&#x02010;19.</alt-title><alt-title alt-title-type="left-running-head">Kwiatkowski</alt-title></title-group><contrib-group><contrib id="uog22049-cr-0001" contrib-type="author"><name><surname>Kwiatkowski</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="uog22049-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="uog22049-cr-0002" contrib-type="author"><name><surname>Borowski</surname><given-names>D.</given-names></name><xref ref-type="aff" rid="uog22049-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="uog22049-cr-0003" contrib-type="author" corresp="yes"><name><surname>Kajdy</surname><given-names>A.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3581-8120</contrib-id><xref ref-type="aff" rid="uog22049-aff-0003">
<sup>3</sup>
</xref><address><email>anna.kajdy@cmkp.edu.pl</email></address></contrib><contrib id="uog22049-cr-0004" contrib-type="author"><name><surname>Poon</surname><given-names>L. C.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3944-4130</contrib-id><xref ref-type="aff" rid="uog22049-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="uog22049-cr-0005" contrib-type="author"><name><surname>Rokita</surname><given-names>W.</given-names></name><xref ref-type="aff" rid="uog22049-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="uog22049-cr-0006" contrib-type="author"><name><surname>Wielgos</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="uog22049-aff-0006">
<sup>6</sup>
</xref></contrib></contrib-group><aff id="uog22049-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Clinical Department of Obstetrics and Gynecology</named-content>
<institution>Pomeranian Medical University</institution>
<city>Szczecin</city>
<country country="PL">Poland</country>
</aff><aff id="uog22049-aff-0002">
<label><sup>2</sup></label>
<institution>Ludwik Rydygier Collegium Medicum</institution>
<city>Bydgoszcz</city>
<country country="PL">Poland</country>
</aff><aff id="uog22049-aff-0003">
<label><sup>3</sup></label>
<institution>Department of Reproductive Health, Centre of Postgraduate Medical Education</institution>
<city>Warsaw</city>
<country country="PL">Poland</country>
</aff><aff id="uog22049-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Obstetrics and Gynecology</named-content>
<institution>The Chinese University of Hong Kong</institution>
<country country="HK">Hong Kong SAR</country>
</aff><aff id="uog22049-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Faculty of Medicine and Health Sciences</named-content>
<institution>Jan Kochanowski University</institution>
<city>Kielce</city>
<country country="PL">Poland</country>
</aff><aff id="uog22049-aff-0006">
<label><sup>6</sup></label>
<named-content content-type="organisation-division">1<sup>st</sup> Department of Obstetrics and Gynecology</named-content>
<institution>Medical University of Warsaw</institution>
<city>Warsaw</city>
<country country="PL">Poland</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><italic>Correspondence</italic>. (e&#x02010;mail: <email>anna.kajdy@cmkp.edu.pl</email>)</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>6</month><year>2020</year></pub-date><volume>55</volume><issue>6</issue><issue-id pub-id-type="doi">10.1002/uog.v55.6</issue-id><fpage>841</fpage><lpage>843</lpage><history><date date-type="received"><day>22</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>27</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>06</day><month>4</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 ISUOG. Published by John Wiley & Sons Ltd <copyright-statement>--><copyright-statement content-type="article-copyright">Copyright &#x000a9; 2019 ISUOG. Published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:UOG-55-841.pdf"/><counts><fig-count count="0"/><table-count count="0"/><page-count count="2"/><word-count count="1200"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.3 mode:remove_FC converted:02.06.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="uog22049-body-0001"><p>During the current coronavirus disease 2019 (COVID&#x02010;19) pandemic, several questions have arisen relating to the management of pregnant women. The risk of COVID&#x02010;19 to pregnant women may be much lower than in the previous SARS epidemic. The case fatality rates (CFR) in pregnant women during the SARS and MERS epidemics were 15% and 27%, respectively<xref rid="uog22049-bib-0001" ref-type="ref">1</xref>, <xref rid="uog22049-bib-0002" ref-type="ref">2</xref>, while COVID&#x02010;19 seems to have a milder natural history<xref rid="uog22049-bib-0002" ref-type="ref">2</xref>. The available data regarding COVID&#x02010;19 are limited; therefore, maternal outcomes may be underreported at present.</p><p>Published observations in non&#x02010;pregnant patients have shown that non&#x02010;steroidal anti&#x02010;inflammatory drugs (NSAIDs), such as ibuprofen, can cause progression of pulmonary disease. This relationship has been observed in bacterial pulmonary infections. Experimental data suggest that NSAIDs alter the function of neutrophils and delay bacterial clearance and inflammation resolution<xref rid="uog22049-bib-0003" ref-type="ref">3</xref>, <xref rid="uog22049-bib-0004" ref-type="ref">4</xref>. Observational data suggest an association between exposure to NSAIDs and the occurrence of pleuropulmonary complications (pleural empyema, excavation and abscess). Similar observations have also been made in a small group of young people taking ibuprofen for COVID&#x02010;19 symptoms<xref rid="uog22049-bib-0003" ref-type="ref">3</xref>, <xref rid="uog22049-bib-0004" ref-type="ref">4</xref>. As a result, French health officials have issued a precaution regarding the use of NSAIDs, including aspirin. This has started an international debate among healthcare professionals regarding the usage of NSAIDs, primarily ibuprofen, in patients with COVID&#x02010;19<xref rid="uog22049-bib-0005" ref-type="ref">5</xref>. The Spanish Ministry of Health has stated that there is no evidence that ibuprofen (or other NSAIDs) could worsen SARS&#x02010;CoV&#x02010;2 infection. However, it stated that ibuprofen might mask the symptoms of infection, therefore delaying diagnosis<xref rid="uog22049-bib-0006" ref-type="ref">6</xref>. The Royal College of Obstetricians and Gynaecologists in the UK recommends paracetamol for COVID&#x02010;19 symptoms<xref rid="uog22049-bib-0007" ref-type="ref">7</xref>.</p><p>There is therefore cause for concern regarding the wellbeing of pregnant women taking aspirin for prophylaxis of pre&#x02010;eclampsia and fetal growth restriction. The debate could have resulted in a misunderstanding among both healthcare professionals and pregnant women, leading to withdrawal of prophylactic low&#x02010;dose aspirin therapy. Currently, there are no available data regarding the association between the risk of COVID&#x02010;19 progression and intake of low&#x02010;dose aspirin.</p><p>Pre&#x02010;eclampsia affects 2&#x02013;8% of pregnancies worldwide and is one of the leading causes of maternal death and perinatal mortality and morbidity<xref rid="uog22049-bib-0008" ref-type="ref">8</xref>. Currently, around the world, there are more than 350&#x02009;536 active cases of COVID&#x02010;19 and this number is increasing every day<xref rid="uog22049-bib-0009" ref-type="ref">9</xref>. On the other hand, there are fewer than 100 published cases of COVID&#x02010;19 in pregnant women. Based on these case series and reports, it appears that the natural history of SARS&#x02010;CoV&#x02010;2 infection among pregnant women is not different from that in non&#x02010;pregnant adults. A World Health Organization (WHO) report from China states that only 1% of the described cases in pregnant women have been critical and 8% were severe<xref rid="uog22049-bib-0010" ref-type="ref">10</xref>. At the time of writing, there were no reported maternal deaths related to SARS&#x02010;CoV&#x02010;2 infection. None of the cases of COVID&#x02010;19 in pregnant women in the series of Schwartz was severe<xref rid="uog22049-bib-0011" ref-type="ref">11</xref>.</p><p>Low&#x02010;dose aspirin has been proven to be an effective regimen for the prevention of placental complications during pregnancy, including pre&#x02010;eclampsia and fetal growth restriction. Intake of low&#x02010;dose aspirin during pregnancy is not associated with an increased risk of congenital defects, bleeding or premature closure of the ductus arteriosus<xref rid="uog22049-bib-0008" ref-type="ref">8</xref>. The recommended dosage of 150&#x02009;mg of aspirin daily for the prevention of pre&#x02010;eclampsia is based on the results of the ASPRE trial. In the trial, preterm pre&#x02010;eclampsia occurred in 1.6% of women in the low&#x02010;dose aspirin group, as compared with 4.3% in the placebo group (odds ratio, 0.38; 95%&#x02009;CI, 0.20&#x02013;0.74; <italic>P</italic>&#x02009;=&#x02009;0.004)<xref rid="uog22049-bib-0008" ref-type="ref">8</xref>.</p><p>The WHO has published an official statement recommending not to avoid the use of ibuprofen based on the current available data<xref rid="uog22049-bib-0012" ref-type="ref">12</xref>. To our knowledge, there are limited data to suggest that there is an association between prophylactic use of low&#x02010;dose aspirin and increased risk of progression of SARS&#x02010;CoV&#x02010;2 infection.</p><p>In our opinion, during the COVID&#x02010;19 pandemic, it is still essential to provide first&#x02010;trimester screening for placental complications and to prescribe low&#x02010;dose aspirin in women who are identified as high risk for pre&#x02010;eclampsia and fetal growth restriction. Based on the current knowledge of the epidemiological situation, the benefits of placental complication prevention outweigh the potential risks of adverse outcome related to the usage of low&#x02010;dose aspirin in patients with SARS&#x02010;CoV&#x02010;2 infection.</p></body><back><ref-list id="uog22049-bibl-0001" content-type="cited-references"><title>References</title><ref id="uog22049-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="uog22049-cit-0001">
<string-name>
<surname>Schwartz</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>AL</given-names>
</string-name>. <article-title>Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019&#x02010;nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections</article-title>. <source xml:lang="en">Viruses</source>
<year>2020</year>; <volume>12</volume>: <elocation-id>E194</elocation-id>.<pub-id pub-id-type="pmid">32050635</pub-id></mixed-citation></ref><ref id="uog22049-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="uog22049-cit-0002">
<string-name>
<surname>Mullins</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Evans</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Viner</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>O'Brien</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>E</given-names>
</string-name>. <article-title>Coronavirus in pregnancy and delivery: rapid review</article-title>. <source xml:lang="en">Ultrasound Obstet Gynecol</source>
<year>2020</year>; <volume>55</volume>: <fpage>586</fpage>&#x02013;<lpage>592</lpage>.<pub-id pub-id-type="pmid">32180292</pub-id></mixed-citation></ref><ref id="uog22049-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="uog22049-cit-0003">
<string-name>
<surname>Day</surname>
<given-names>M.</given-names>
</string-name>
<article-title>Covid&#x02010;19: ibuprofen should not be used for managing symptoms, say doctors and scientists</article-title>. <source xml:lang="en">BMJ</source>
<year>2020</year>; <volume>368</volume>: <fpage>m1086</fpage>.<pub-id pub-id-type="pmid">32184201</pub-id></mixed-citation></ref><ref id="uog22049-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="uog22049-cit-0004">
<string-name>
<surname>Voiriot</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chalumeau</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Messika</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Basille</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Philippe</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Ricard</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Andrejak</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Jounieaux</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sanchez</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Fartoukh</surname>
<given-names>M</given-names>
</string-name>. [<article-title>Risks associated with the use of non&#x02010;steroidal anti&#x02010;inflammatory drugs during pneumonia</article-title>]. <source xml:lang="en">Rev Mal Respir</source>
<year>2018</year>; <volume>35</volume>: <fpage>430</fpage>&#x02013;<lpage>440</lpage>.<pub-id pub-id-type="pmid">29754841</pub-id></mixed-citation></ref><ref id="uog22049-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="uog22049-cit-0005">
<string-name>
<surname>FitzGerald</surname>
<given-names>GA</given-names>
</string-name>. <article-title>Misguided drug advice for COVID&#x02010;19</article-title>. <source xml:lang="en">Science</source>
<year>2020</year>; <volume>367</volume>: <fpage>1434</fpage>.</mixed-citation></ref><ref id="uog22049-bib-0006"><label>6</label><mixed-citation publication-type="miscellaneous" id="uog22049-cit-0006">Agencia Espa&#x000f1;ola de Medicamentos y Productos Sanitarios, <year>2020</year> La AEMPS informa que ning&#x000fa;n dato indica que el ibuprofeno agrave las infecciones por COVID&#x02010;19. <ext-link ext-link-type="uri" xlink:href="https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/la-aemps-informa-que-ningun-dato-indica-que-el-ibuprofeno-agrave-las-infecciones-por-covid-19/">https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/2020-medicamentosusohumano-3/la-aemps-informa-que-ningun-dato-indica-que-el-ibuprofeno-agrave-las-infecciones-por-covid-19/</ext-link> [Accessed 26 March 2020]</mixed-citation></ref><ref id="uog22049-bib-0007"><label>7</label><mixed-citation publication-type="miscellaneous" id="uog22049-cit-0007">Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID&#x02010;19) infection and pregnancy. <ext-link ext-link-type="uri" xlink:href="https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/">https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/</ext-link> [Accessed 26 March 2020]</mixed-citation></ref><ref id="uog22049-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="uog22049-cit-0008">
<string-name>
<surname>Rolnik</surname>
<given-names>DL</given-names>
</string-name>, <string-name>
<surname>Wright</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Poon</surname>
<given-names>LCY</given-names>
</string-name>, <string-name>
<surname>Syngelaki</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>O'Gorman</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>de Paco</surname>
<given-names>Matallana C</given-names>
</string-name>, <string-name>
<surname>Akolekar</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Cicero</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Janga</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Molina</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Persico</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jani</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Plasencia</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Papaioannou</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Tenenbaum&#x02010;Gavish</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Nicolaides</surname>
<given-names>KH</given-names>
</string-name>. <article-title>ASPRE trial: performance of screening for preterm pre&#x02010;eclampsia</article-title>. <source xml:lang="en">Ultrasound Obstet Gynecol</source>
<year>2017</year>; <volume>50</volume>: <fpage>492</fpage>&#x02013;<lpage>495</lpage>.<pub-id pub-id-type="pmid">28741785</pub-id></mixed-citation></ref><ref id="uog22049-bib-0009"><label>9</label><mixed-citation publication-type="miscellaneous" id="uog22049-cit-0009">Johns Hopkins University. Coronavirus COVID&#x02010;19 (2019&#x02010;nCoV). <ext-link ext-link-type="uri" xlink:href="https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6">https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6</ext-link> [Accessed 23 March 2020]</mixed-citation></ref><ref id="uog22049-bib-0010"><label>10</label><mixed-citation publication-type="miscellaneous" id="uog22049-cit-0010">Report of the WHO&#x02010;China Joint Mission on Coronavirus Disease 2019 (COVID&#x02010;19). <ext-link ext-link-type="uri" xlink:href="https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf">https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf</ext-link> [Accessed 26 March 2020]</mixed-citation></ref><ref id="uog22049-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="uog22049-cit-0011">
<string-name>
<surname>Schwartz</surname>
<given-names>DA</given-names>
</string-name>. <article-title>An Analysis of 38 Pregnant Women with COVID&#x02010;19, Their Newborn Infants, and Maternal&#x02010;Fetal Transmission of SARS&#x02010;CoV&#x02010;2: Maternal Coronavirus Infections and Pregnancy Outcomes</article-title>. <source xml:lang="en">Arch Pathol Lab Med</source>
<year>2020</year> DOI: <pub-id pub-id-type="doi">10.5858/arpa.2020-0901-SA</pub-id>.</mixed-citation></ref><ref id="uog22049-bib-0012"><label>12</label><mixed-citation publication-type="miscellaneous" id="uog22049-cit-0012">Updated: WHO Now Doesn't Recommend Avoiding Ibuprofen For COVID&#x02010;19 Symptoms. <ext-link ext-link-type="uri" xlink:href="https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms">https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms</ext-link> [Accessed 23 March 2020]</mixed-citation></ref></ref-list></back></article>